Health & Safety

August 10, 2012

Laboratory developed tests covered under TRICARE demonstration may help guide cancer treatment decisions

by TRICARE Public Affairs

Some TRICARE beneficiaries will soon be able to take advantage of new technologies aimed at helping patients and healthcare providers make more informed decisions regarding treatment options for surgery, chemotherapy or radiation therapy for some types of cancer.

On May 22, 2012, two laboratory developed tests were approved for coverage by TRICARE under a demonstration project: the BRACAnalysis BRCA1 and BRCA2 tests (Myriad Genetic Laboratories, Inc.), and also, the Oncotype DX Breast Cancer Assay (Genomic Health, Inc.).

BRACAnalysis testing assesses a woman’s risk of developing hereditary breast or ovarian cancers based on detection of mutations in their BRCA1 and BRCA2 genes. The Oncotype DX breast cancer assay is a test that examines a breast cancer patient’s tumor tissue at the molecular level; specifically, it is hoped that this information can help individualize the planning of the patient’s breast cancer treatment. The complete description of this demonstration project is available at www.gpo.gov/fdsys/pkg/FR-2011-12-27/html/2011-33066.htm.

The criteria for which of these tests will be covered by TRICARE are scheduled to be published in the TRICARE Operations Manual in August 2012. TRICARE providers will be prepared to accept patients under the demonstration project by September 30, 2012; however, coverage for the approved use of these tests is retroactive to May 22, 2012. Beneficiaries should speak with their primary health care professional or their regional contractor to determine their eligibility for having these tests performed as a TRICARE benefit. Find regional contractor contact information at www.tricare.mil/contactus.




All of this week's top headlines to your email every Friday.


 
 

 
recall

Kidde recalls disposable plastic fire extinguishers due to failure to discharge

The Edwards AFB Fire Department has announced an important recall of Kidde plastic valve disposable fire extinguishers. The recall applies to both notify base residents and the local community. According to the Consumer Product...
 
 

Small increase to TRICARE pharmacy copays began Feb. 1

New copayments for prescription drugs covered by TRICARE went into effect Feb. 1. The Fiscal Year 2015 National Defense Authorization Act requires TRICARE to increase most pharmacy copays by $3. Drugs from military pharmacies and generic drugs from TRICARE Pharmacy Home Delivery still cost beneficiaries $0. TRICARE pharmacy copays vary based on the class of...
 
 
vaccine

Measles: Don’t wait, vaccinate

Air Force photograph The 412th Medical Group is urging individuals and parents to vaccinate themselves and their children if they are not immunized. Measles is caused by a highly contagious virus and is easily spread through dr...
 

 
MDG-no-show

Don’t be a ‘no show’

The 412th Medical Group is dedicated to meeting the health care needs of you and your family by providing access to its services and the best possible medical care. No shows are a costly problem for the 412th MDG and the patien...
 
 

TRICARE and the Affordable Care Act

With the implementation of the Patient Protection and Affordable Care Act in 2010, TRICARE beneficiaries may have questions about how it would affect them. The ACA and TRICARE are very different, governed by two different pieces of legislation so changes in one have no effect on the other. The intent of the Affordable Care Act,...
 
 
heart-month

AFMC promotes awareness of heart attack warning signs

February is American Heart Month. The National Institutes of Health reports that more than one million people in the United States have a heart attack each year. Of the people who die from heart attacks, about half die within a...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>